REGN475
R475-PN-1004
Phase 2 mab terminated
Quick answer
REGN475 for Osteoarthritis is a Phase 2 program (mab) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Osteoarthritis
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated